“Our expansion into the D.C. market represents a natural extension of our thematic investing approach and partnership with Evergreen, which seeks to identify and add value to high-quality medical ...

EXCLUSIVE: The adaptation of Booker Prize-winner Shuggie Bain has emerged as one of the BBC’s “stuck in limbo” projects as drama boss Lindsay Salt blames a “perfect storm” for the ...

In the US, more and more doctors are now affiliated with the hospital conglomerates or Wall Street firms taking over the ...

Are you an aspiring management consultant? Find out what salary you could earn at Bain & Company with an MBA or master’s degree Wed Jan 29 2025 Bain & Company has been ranked the best company to work ...

Wells Fargo analyst Finian O’Shea maintained a Buy rating on Bain Capital Specialty Finance (BCSF – Research Report) today and set a price target of $18.00. The company’s shares closed yeste ...

Jan 13 (Reuters) - Shares of Australia's Insignia Financial (IFL.AX), opens new tab hit a more than three-year high on Monday as a bidding war escalated, with private equity firm Bain Capital ...

Omega Healthcare Investors Inc. 0.60% $9.94B ...

Gift 5 articles to anyone you choose each month when you subscribe. It’s mano-a-mano at Insignia Financial, the ASX-listed wealth giant put into play by Bain Capital in December. Street Talk ...

Under the offer, Insignia shareholders will receive A$4.30 per share, a 7.5% premium to Bain Capital's earlier offer and a 4.4% premium to Insignia's last closing price of A$4.120.

That's 7.5% higher than the already rejected, opens new tab offer Bain Capital, opens new tab put on the table last month, and a 40% premium to Insignia's undisturbed price. It shows the allure of ...

BofA analyst Joanna Gajuk is moving to No Rating on Surgery Partners (SGRY) after Bain Capital made a non-binding proposal to buy the 61% stake it does not own for $25.75 per share. While it is ...